October 27, 2025

DaVita Inc. (DVA) Investor Outlook: Evaluating Growth Potential Amid a 16.50% Upside

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector, remains a focal point for investors interested in the medical care facilities industry. With a market capitalization of $9.24..

Henry Schein, Inc. (HSIC) Stock Analysis: Is a 14.59% Upside on the Horizon?

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, commands a robust market presence in the medical distribution industry with a market capitalization of $7.74 billion. Headquartered in..

Mettler-Toledo International (MTD) Stock Analysis: Navigating a -7.05% Potential Downside Amidst Robust Market Position

Mettler-Toledo International Inc. (NYSE: MTD) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $29.55 billion, this Ohio-based..

CVS Health Corporation (CVS) Stock Analysis: Navigating Growth with a 5.21% Upside Potential

As CVS Health Corporation (NYSE: CVS) continues to be a cornerstone in the healthcare sector, investors are keenly observing its performance metrics and market potential. With a market capitalization of..

Encompass Health Corporation (EHC) Stock Analysis: Strong Buy Ratings and a 10% Potential Upside

Encompass Health Corporation (NYSE: EHC) is a prominent player in the healthcare sector, specializing in post-acute services with a focus on inpatient rehabilitation. As an investor, the compelling growth prospects..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Market Challenges with Resilient Healthcare Innovations

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its expansive portfolio of single-use medical devices...

Fresenius Medical Care AG (FMS) Stock Analysis: An Insightful Look at Growth Potential and Market Position

Fresenius Medical Care AG (FMS) stands as a pivotal player in the healthcare sector, specifically within the medical care facilities industry. With a market cap of $15.99 billion, the company..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A 21.57% Upside Potential in the Booming Biotechnology Sector

For investors with a keen eye on the healthcare industry, Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) presents a compelling opportunity within the biotechnology sector. Known for its innovative therapeutic approaches, Madrigal..

Cencora, Inc. (COR) Stock Analysis: Riding High on Healthcare with a 116.71% ROE

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector specializing in medical distribution, has been capturing investor attention with its robust return on equity (ROE) of 116.71%. As the..

Incyte Corporation (INCY) Stock Analysis: Navigating a 16.5% Revenue Growth Amidst Market Volatility

Incyte Corporation (INCY), a prominent player in the biotechnology industry, is capturing investor attention with its robust revenue growth of 16.5%. With a market capitalization of $17.82 billion, Incyte stands..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unlocking 94% Upside Potential with Innovative Radiopharmaceuticals

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising portfolio of radiopharmaceutical products. Headquartered in North Melbourne, Australia, this..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Powerhouse with 27.82% Upside Potential

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, is drawing significant attention from investors, thanks to its strong growth metrics and promising future outlook. The..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Insights into a Biotech Powerhouse with 100% Revenue Growth

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, has been making waves with its impressive 100.70% revenue growth, capturing the attention of investors and analysts alike...

Alkermes plc (ALKS) Stock Analysis: Discovering a 46.76% Upside Potential in the Biopharma Space

Investors seeking opportunities in the healthcare sector might find Alkermes plc (NASDAQ: ALKS) an intriguing prospect given its significant upside potential. With a market capitalization of $4.92 billion, this Ireland-based..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Giant with a 6.39% Potential Upside

Doximity, Inc. (NASDAQ: DOCS) is a formidable player in the healthcare technology space, providing an essential digital platform tailored for medical professionals. Headquartered in San Francisco, Doximity has carved out..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 25% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing the attention of investors in the healthcare sector, thanks to its strong growth metrics and favorable analyst ratings. With a market capitalization..

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Assessing a 48% Potential Upside Opportunity

Lantheus Holdings, Inc. (NASDAQ: LNTH), a significant player in the healthcare sector specializing in the development and commercialization of diagnostic and therapeutic products, is capturing investor attention with a notable..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader with Strong Revenue Growth and Analyst Support

Investors with a keen eye on the healthcare sector should take a closer look at The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the medical care facilities industry...

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Biotech Giant with 10% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) has emerged as a key player in the biotechnology sector, offering a unique investment opportunity with its robust pipeline and strategic focus on developing breakthrough..

Search

Funds

October 27, 2025

Search

Funds

October 27, 2025

FTSE 100

Funds